The exosome research market is a sector within the life sciences and biotechnology industry that is dedicated to studying and utilizing exosomes, small extracellular vesicles secreted by cells. Exosomes play a crucial role in intercellular communication and are being extensively researched for their potential applications in diagnostics, drug delivery, and regenerative medicine. This market includes exosome isolation and analysis kits, as well as exosome-based therapeutics and diagnostics. It caters to research institutions, biotechnology companies, and pharmaceutical firms exploring the therapeutic potential of exosomes.
According to the new market research report "Exosome Research Market Size, Growth by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User & Region - Global Forecast to 2026"
The global exosome research market in terms of revenue was estimated to be worth $144 million in 2021 and is poised to reach $661 million by 2026, growing at a CAGR of 35.6% from 2021 to 2026.
Request Sample Pages: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=224782498
Drivers: Increasing investments in pharmaceutical R&D and life science research
Most pharmaceutical, biopharmaceutical, and medical device companies invest heavily in developing novel drugs and devices. The pharmaceutical industry is R&D-intensive. Pharmaceutical companies invest in R&D to deliver high-quality and innovative products to the market. Trends suggest that the top pharma companies are increasing their R&D efficiencies through heavy R&D investments to see returns in the longer term and through collaborative R&D efforts. According to the EvaluatePharma report, worldwide pharmaceutical R&D spending was valued at USD 136 billion in 2012; this increased to USD 186 billion in 2019. As a result of the COVID-19 outbreak, the global pharma R&D growth rate dropped to 0.3% in 2020. As per the report, this R&D spend is expected to grow steadily between 2019 and 2026 at a CAGR of 3.2% to reach USD 232.5 billion, slower than the historical CAGR of 4.6% between 2012 and 2019.
Thermo Fisher Scientific (US), Bio-Techne (US), Lonza (Switzerland), QIAGEN (Germany), Miltenyi Biotec (US), are the prominent players operating in the exosome research market.
Report Objectives
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.marketsandmarkets.com/Market-Reports/exosome-research-product-market-224782498.html
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn, and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]
